Detalles de la búsqueda
1.
Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model.
Eur Radiol
; 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329503
2.
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial.
Breast Cancer Res Treat
; 197(3): 525-533, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525180
3.
Predictors of Nodal Pathological Complete Response in Asian Women with Stage II-III Node-Positive Breast Cancer.
Oncology
; 99(6): 359-364, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33735903
4.
Limb salvage after aneurysmal degeneration of a cryopreserved vein allograft: Searching the autologous veins of the arm is worth the effort.
Morphologie
; 104(346): 202-213, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32518049
5.
Donkey pericardium compares favorably with commercial xenopericardia used in the manufacture of transcatheter heart valves.
Artif Organs
; 43(10): 976-987, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31140630
6.
Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era.
World J Surg Oncol
; 17(1): 37, 2019 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30786903
7.
Short-term outcomes of the over-the-scope clip proctology system for rectovaginal fistula repair: a prospective study.
Tech Coloproctol
; 23(3): 245-249, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30937645
8.
Clinical characteristics, tumor-infiltrating lymphocytes, and prognosis in HER2-low breast cancer: A comparison study with HER2-zero and HER2-positive disease.
Cancer Med
; 12(15): 16264-16278, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37366301
9.
A Breeding Plumage in the Making: The Unique Process of Plumage Coloration in the Crested Ibis in Terms of Chemical Composition and Sex Hormones.
Animals (Basel)
; 13(24)2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38136856
10.
Ki67 increase after core needle biopsy associated with worse disease outcome in HER2-negative breast cancer patients.
Sci Rep
; 13(1): 2489, 2023 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36781892
11.
Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer.
Cancer Commun (Lond)
; 43(6): 661-684, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37158690
12.
Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients.
Front Oncol
; 12: 845823, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35936729
13.
Association of Obesity and Luminal Subtypes in Prognosis and Adjuvant Endocrine Treatment Effectiveness Prediction in Chinese Breast Cancer Patients.
Front Oncol
; 12: 862224, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35600356
14.
Can HER2 1+ Breast Cancer Be Considered as HER2-Low Tumor? A Comparison of Clinicopathological Features, Quantitative HER2 mRNA Levels, and Prognosis among HER2-Negative Breast Cancer.
Cancers (Basel)
; 14(17)2022 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077795
15.
HER2-Low Status Is Not Accurate in Breast Cancer Core Needle Biopsy Samples: An Analysis of 5610 Consecutive Patients.
Cancers (Basel)
; 14(24)2022 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551684
16.
Association of machine learning ultrasound radiomics and disease outcome in triple negative breast cancer.
Am J Cancer Res
; 12(1): 152-164, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35141010
17.
Association of tumor immune microenvironment profiling and 21-gene recurrence assay in early breast cancer patients.
Eur J Med Res
; 27(1): 293, 2022 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36528658
18.
Prognostic Factors and Surgery for Breast Cancer Patients With Locoregional Recurrence: An Analysis of 5,202 Consecutive Patients.
Front Oncol
; 11: 763119, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34722317
19.
Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer Patients.
Front Oncol
; 11: 638619, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34277399
20.
21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer Patients.
Front Endocrinol (Lausanne)
; 12: 725161, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34456877